D. Aletaha

Minimal disease activity for rheumatoid arthritis: A preliminary definition (2005)

Wells, G. A., Boers, M., Shea, B., Brooks, P. M., Simon, L. S., Strand, C. V., ...

Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of...

Minimal disease activity for rheumatoid arthritis: A preliminary definition (2005)

Wells, G. A., Boers, M., Shea, B., Brooks, P. M., Simon, L. S., Strand, C. V., ...

Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of...

Minimal disease activity for rheumatoid arthritis: A preliminary definition (2005)

Wells, G. A., Boers, M., Shea, B., Brooks, P. M., Simon, L. S., Strand, C. V., ...

Agreement on response criteria in rheumatoid arthritis (RA) has allowed better standardization and interpretation of clinical trial reports. With recent advances in therapy, the proportion of...

Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years

Aletaha, D, Eberl, G, Nell, V, Machold, K, Smolen, J

Background: Early diagnosis and treatment with disease modifying antirheumatic drugs (DMARDs) have been advocated for patients with rheumatoid arthritis (RA). This survey focuses on the individual...

Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study

Aletaha, D, Stamm, T, Kapral, T, Eberl, G, Grisar, J, Machold, K, ...

Objective: To determine the survival and clinical effectiveness of leflunomide (LEF) compared with methotrexate (MTX) and sulfasalazine (SSZ) for RA in an observational study.

Authors' reply

Aletaha, D, Smolen, J

Toxicity profiles of traditional disease modifying antirheumatic drugs for rheumatoid arthritis

Aletaha, D, Kapral, T, Smolen, J

Objective: To explore the toxicity profiles of DMARDs in daily life.

Patients with rheumatoid arthritis in clinical care

Smolen, J, Aletaha, D

Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey

Aletaha, D, Eberl, G, Nell, V, Machold, K, Smolen, J

Objective: To determine if rheumatologists have changed their views on diagnosis and treatment of early rheumatoid arthritis (RA).

The burden of rheumatoid arthritis and access to treatment: a medical overview

J. Smolen, D. Aletaha

Rheumatoid arthritis, A, A1, A10, A31, I11,